% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

  • jesse77727 jesse77727 Aug 8, 2013 2:40 PM Flag

    IMGN CHART - New Investor

    I've been watching IMGN for a while and this is why I took a position earlier today:

    Take a look at the close on April 18....14.25.....bottomed......Take a look at the close on June 20....15.37.....bottomed again.......The increase in the bottoms was about 8%.....That brings us to today......Another 8% increase from the June 20 bottom puts us at about $16.59.......Catch my drift

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I added more shares today at $17.01.....took some profits from SOL ahead of earnings tomorrow morning.

      Sentiment: Strong Buy

    • It is a simple to forecast that Immunogen's share price should grow as Kadcyla sales increase. Roche is intent on transitioning essentially their entire Herceptin franchise over to Kadcyla by around 2018 when the patent expires. By then we should see label expansions in all breast cancer indications, and Kadcyla is likely to be adopted as the new standard of care. We will also be looking at further expansion into other HER 2+ cancers by then as well.

      Herceptin sales for all of 2012 were ~$6.36 billion. Kadcyla is priced at 2.2x what Herceptin was, thus the Kadcyla franchise could be expected to grow to as much as $13.9 billion. Just on a straight 5% royalty that is $695 million. Outstanding shares for Immunogen stand at around 85 million. That is $8 and change in earning per share. Anything else in the pipeline that works out is gravy.

      Chinese Hamsters

    • I bought some OMED today....Hard to resist....two initiations with a $29 and $30 price target for a stock that is trading a little over $18 and is having a down day.

      Sentiment: Strong Buy

    • Go ahead and complete your analysis while you're at it. Where will the next top take us?

      • 1 Reply to slumdawg2011
      • I'll take a stab long and short.
        July 11, 2011....15.40....July 2 2012....17.48....about 13% higher year over year....July 12, 2013....19.67...again about 13% higher year over year. Taking in to account IMGN should have more drugs advancing into phase 3 within the next year then they have had previously, instead of 13% year over year again I will anticipate closer to 20% over July 12, 2013 19.67....So that being said....

        Expecting it to be around 23.60 July 2014.

        Next Top: I'm looking at the tops on April 11,2013....17.78.....May 30, 2013.....18.39.....July 12, 2013....19.67.....Next top I think should be about 9% above July, 12....19.67

        Expecting next top to be close to $21.44

        Sentiment: Strong Buy

2.68+0.03(+1.13%)Sep 30 4:00 PMEDT